EP3250575
Tósýlatsalt af N-[3-[(4aR,7aS)-2-amínó-6-(5-flúrpýrímídín-2-ýl)-4,4a,5,7-tetrahýdrópýrróló[3,4-d][1,3]þíasín-7a-ýl]-4-flúr-fenýl]-5-met oxý-pýrasín-2-karboxamíði
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.1.2016EP published:
20.11.2019EP application number:
16702654.1
EP translation filed:
16.12.2019Grant published:
15.1.2020EPO information:
European Patent Register
Max expiry date:
21.1.2036Expiry date:
21.1.2027Next due date:
31.1.2027
Title:
TOSYLATE SALT OF N-[3-[(4AR,7AS)-2-AMINO-6-(5-FLUOROPYRIMIDIN-2-YL)-4,4A,5,7-TETRAHYDROPYRROLO[3,4-D][1,3]THIAZIN-7A-YL]-4-FLUORO-PHENYL]-5-METHOXY-PYRAZINE-2-CARBOXAMIDE.
Timeline
Today
22.1.2016EP application
20.11.2019EP Publication
16.12.2019Translation submitted
15.1.2020Registration published
21.1.2027Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, 46285, Indianapolis, IN, US
Inventor
Name:
COATES, David AndrewAddress:
Indianapolis, Indiana, US
Name:
WOLFANGEL, Craig DanielAddress:
Indianapolis, Indiana, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562109733 PDate:
30.1.2015Country:
US
Classification
Categories:
C07D 513/04, A61K 31/542, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 10.1.2020
Expires: 21.1.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 17.12.2020
Expires: 21.1.2022
Payer: Patice ehf.
Number: 7
Paid: 15.12.2021
Expires: 21.1.2023
Payer: Patice ehf.
Number: 8
Paid: 22.12.2022
Expires: 21.1.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 20.12.2023
Expires: 21.1.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.1.2025
Expires: 21.1.2026
Payer: Árnason Faktor ehf.
Number: 11
Paid: 12.1.2026
Expires: 21.1.2027
Payer: Árnason Faktor ehf.